Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel

Author:

Buchek Gregory12,Mende Katrin134,Telu Kalyani34,Kaiser Susan134,Fraser Jamie34,Mitra Indrani34,Stam Jason5,Lalani Tahaniyat34,Tribble David3,Yun Heather C12

Affiliation:

1. Brooke Army Medical Center, JBSA Fort Sam Houston, TX, USA

2. Uniformed Services University of the Health Sciences, Bethesda, MD, USA

3. Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

4. Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA

5. Walter Reed Army Institute of Research, Silver Spring, MD, USA

Abstract

Abstract Background International travel is a risk factor for incident colonization with extended spectrum beta-lactamase (ESBL)-producing organisms. These and other multidrug-resistant (MDR) bacteria are major pathogens in combat casualties. We evaluated risk factors for colonization with MDR bacteria in US military personnel travelling internationally for official duty. Methods TravMil is a prospective observational study enrolling subjects presenting to military travel clinics. We analysed surveys, antimicrobial use data, and pre- and post-travel perirectal swabs in military travellers to regions outside the continental USA, Canada, Western or Northern Europe, or New Zealand, presenting to one clinic from 12/2015 to 12/2017. Recovered Gram-negative isolates underwent identification and susceptibility testing (BD Phoenix). Characteristics of trip and traveller were analysed to determine risk factors for MDR organism colonization. Results 110 trips were planned by 99 travellers (74% male, median age 38 years [IQR 31, 47.25]); 72 trips with returned pre- and post-travel swabs were completed by 64 travellers. Median duration was 21 days (IQR 12.75, 79.5). 17% travelled to Mexico/Caribbean/Central America, 15% to Asia, 57% to Africa and 10% to South America; 56% stayed in hotels and 50% in dormitories/barracks. Travellers used doxycycline (15%) for malaria prophylaxis, 11% took an antibiotic for travellers’ diarrhoea (TD) treatment (fluoroquinolone 7%, azithromycin 4%). Incident MDR organism colonization occurred in 8 travellers (incidence density 3.5/1000 travel days; cumulative incidence 11% of trips [95% CI: 4–19%]), all ESBL-producing Escherichia coli. A higher incidence of ESBL-producing E. coli acquisition was associated with travel to Asia (36% vs 7%, P = 0.02) but not with travel to other regions, TD or use of antimicrobials. No relationship was seen between fluoroquinolone or doxycycline exposure and resistance to those antimicrobials. Conclusions Incident colonization with MDR organisms occurs at a lower rate in this military population compared with civilian travellers, with no identified modifiable risk factors, with highest incidence of ESBL acquisition observed after South Asia travel.

Funder

Infectious Disease Clinical Research Program

Uniformed Services University of the Health Sciences

Henry M. Jackson Foundation

Advancement of Military Medicine, Inc.

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Department of Defense Global Emerging Infections Surveillance

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Reference25 articles.

1. Antimicrobial resistance: a global public health emergency further exacerbated by international travel;Holubar;J Travel Med,2020

2. Acquisition of multidrug-resistant gram-negative organisms during travel;Murray;Mil Med,2017

3. Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study;Tribble;J Trauma,2011

4. Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq;Hospenthal;J Trauma,2011

5. Antimicrobial resistance acquisition after international travel in U.S. Travelers;Blyth;Trop Dis Travel Med Vaccines,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3